Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...

BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and Month 6 (n=5); 17 of 18 ...

Interim data from Wave Life Sciences' INLIGHT trial showed promising results for WVE-007, an investigational treatment for obesity.

Chronic stress can lead to high cortisol. Wellness coach Rachel emphasises importance of a balanced diet, strength training, and stress reduction techniques.

Among patients experiencing chronic graft-versus-host disease (cGVHD), the transition of treatment with Niktimvo (axatilimab) ...

Mumbai coach Ajeenkya Patwardhan shares his fitness transformation. He began by tracking his food intake, which led to ...

In the first of its kind to investigate the effects of SPU exercises on patients with coronary artery disease (CAD), authors of a new study published in 2025 in Medicine indicate that SPUs may have ...

“Most of the television commercials that they put up were all about ‘Mamdani, Mamdani, democratic socialists,’” Nassau ...

British stylist and founder of Sylva, Tallulah Harlech, has endured a chronic skin condition for over two decades. Here she ...

The bipedal robot expands the Humanoid portfolio, following the wheeled Alpha platform, which has completed its first ...

BMI and hyperphagia reductions have been observed in patients with PWS treated with setmelanotide at Month 3 (n=8) and Month 6 (n=5); 17 of 18 enrolled patients remain on therapy -- -- Promising ...

There are improved cardiovascular outcomes associated with semaglutide therapy in patients with overweight or obesity without diabetes.